About EPIRUS BIOPHARMACEUTICALS INC
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company, which focuses on building a biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded in 2000 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EPRSQ is 0.000001 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange EPIRUS BIOPHARMACEUTICALS INC stocks are traded under the ticker EPRSQ.
EPIRUS BIOPHARMACEUTICALS INC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
EPRSQ stock is 0% volatile and has beta coefficient of 23.22. Check out the list of the most volatile stocks — is EPIRUS BIOPHARMACEUTICALS INC there?
Yes, you can track EPIRUS BIOPHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
No, EPRSQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EPRSQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EPIRUS BIOPHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EPIRUS BIOPHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EPIRUS BIOPHARMACEUTICALS INC stock shows the sell signal. See more of EPIRUS BIOPHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.